Our Webinars

Addressing the Rapidly Evolving Vaccine Development Landscape

Addressing the Rapidly Evolving Vaccine Development Landscape

Date: Tuesday, June 30, 2020
Time: 11am EDT(NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
Length: 60 minutes

REGISTER

Will COVID-19 spur disruptive innovation in vaccine studies? The current pandemic has put a bright spotlight on vaccine trials, showing why it’s never been more urgent for robust and thoughtful vaccine trial designs that can be executed efficiently and nimbly. Typically shorter in duration relative to other trials, vaccine trials can cause an increased pressure to plan and execute adeptly.

Join VP, Strategic Development, Scott Treiber, along with AMR’s Chief Medical Officer, Dr Jeffrey Rosen, on Tuesday June 30th, 2020 for an upcoming webinar titled ‘Addressing the Rapidly Evolving Vaccine Development Landscape.’ Optimal approaches to study design and execution, with acknowledgement of the specific challenges presented by different trials and disease states, will be explored.

Treiber and Rosen will address current best practices that enhance vaccine trials performance, such as including experienced sites in protocol development and how to focus site selection to maximize patient numbers across fewer sites for reduced variability. They will detail operational guidance like abbreviate ICFs for rapid pre-screening, pre-emptive measures to accelerate enrollment and operational efficiencies that can improve the speed and quality of vaccine trials. Historical case studies (Zika, Dengue, Chikungunya) will be discussed to demonstrate how these changed the approach to subsequent trials.

Each trial presents its own specific challenges. How will the current pandemic inform, adapt, or completely alter some of these proven strategies? Current events put into sharper focus the need for streamlined, accessible technologies that can make vaccine trials quicker, easier and more patient-centric.

Can tools such as ePRO diaries, telemedicine, HIPAA-compliant virtual systems and more aid in delivering results faster while maintaining quality? The presenters will explore these topics and provide practical insights on how vaccine trial planning and execution can evolve moving forward.

Speakers:

  • Scott Treiber, PhD, MBA, Vice President, Strategic Development, Synteract
  • Jeffrey Rosen, MD, Chief Medical Officer, Alliance of MultiSpecialty Research (AMR)


Looking for a previous webinar? Go to our Webinars Archive arrow
x

Submit RFI / RFP

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Synteract General Medicince Clinical Trial Leadership

Linda RawlingsContact us to find out more about our General Medicine expertise and experience

Linda Rawlings, MSc, FIBMS
VP General Medicine

Contact us to find out more about our General Medicine expertise and experience
x

Synteract Rare, Orphan, & Pediatric Diseases Clinical Trial Leadership

Lisa DilworthContact us to find out more about our Pediatric and Rare and Orphan Diseases expertise and experience

Lisa Dilworth
VP, Strategic Development, Rare, Orphan and Pediatric Diseases

Contact us to find out more about our Rare, Orphan, & Pediatric Diseases expertise and experience
x

 

x

 

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required

x

To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required

x

To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

x

Opt In

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required